New patent for Gilead Sciences drug SUNLENCA

Annual Drug Patent Expirations for SUNLENCA Sunlenca is a drug marketed by Gilead Sciences Inc and is included in two NDAs. It is available from one supplier. There are four…

Source


Comments are closed.

Biotechblog